Literature DB >> 12726735

The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11.

Daniel Stone1, Anne Furthmann, Volker Sandig, André Lieber.   

Abstract

The complete DNA sequence and transcription map of human adenovirus type 11 are reported here. This is the first published sequence for a subgenera B human adenovirus and demonstrates a genome organization highly similar to those of other human adenoviruses. All of the genes from the early, intermediate, and late regions are present in the expected locations of the genome for a human adenovirus. The genome size is 34,794 bp in length and has a GC content of 48.9%. Sequence alignment with genomes of groups A (Ad12), C (Ad5), D (Ad17), E (Simian adenovirus 25), and F (Ad40) revealed homologies of 64, 54, 68, 75, and 52%, respectively. Detailed genomic analysis demonstrated that Ads 11 and 35 are highly conserved in all areas except the hexon hypervariable regions and fiber. Similarly, comparison of Ad11 with subgroup E SAV25 revealed poor homology between fibers but high homology in proteins encoded by all other areas of the genome. We propose an evolutionary model in which functional viruses can be reconstituted following fiber substitution from one serotype to another. According to this model either the Ad11 genome is a derivative of Ad35, from which the fiber was substituted with Ad7, or the Ad35 genome is the product of a fiber substitution from Ad21 into the Ad11 genome. This model also provides a possible explanation for the origin of group E Ads, which are evolutionarily derived from a group C fiber substitution into a group B genome.

Entities:  

Mesh:

Year:  2003        PMID: 12726735     DOI: 10.1016/s0042-6822(02)00085-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Authors:  Lennart Holterman; Ronald Vogels; Remko van der Vlugt; Martijn Sieuwerts; Jos Grimbergen; Jorn Kaspers; Eric Geelen; Esmeralda van der Helm; Angelique Lemckert; Gert Gillissen; Sandra Verhaagh; Jerome Custers; David Zuijdgeest; Ben Berkhout; Margreet Bakker; Paul Quax; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Localization of regions in CD46 that interact with adenovirus.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; M Kathryn Liszewski; John P Atkinson; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Development and assessment of human adenovirus type 11 as a gene transfer vector.

Authors:  Daniel Stone; Shaoheng Ni; Zong-Yi Li; Anuj Gaggar; Nelson DiPaolo; Qinghua Feng; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain.

Authors:  Helena Rebelo-de-Andrade; Cristiana Pereira; Marta Gíria; Ema Prudêncio; Maria João Brito; Etelvina Calé; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

5.  Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development.

Authors:  Anjan Purkayastha; Susan E Ditty; Jing Su; John McGraw; Ted L Hadfield; Clark Tibbetts; Donald Seto
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Genomic analyses of recombinant adenovirus type 11a in China.

Authors:  Zhaohui Yang; Zhen Zhu; Liuying Tang; Li Wang; Xiaojuan Tan; Pengbo Yu; Yong Zhang; Xiaoping Tian; Jingjun Wang; Yan Zhang; Dexin Li; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2009-08-12       Impact factor: 5.948

7.  Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11.

Authors:  Han Hsi Wong; Guozhong Jiang; Rathi Gangeswaran; Pengju Wang; Jiwei Wang; Ming Yuan; Hexiao Wang; Vipul Bhakta; Heike Müller; Nicholas R Lemoine; Yaohe Wang
Journal:  Mol Ther       Date:  2011-11-15       Impact factor: 11.454

8.  Co-infections of adenovirus species in previously vaccinated patients.

Authors:  Gary J Vora; Baochuan Lin; Kevin Gratwick; Carolyn Meador; Christian Hansen; Clark Tibbetts; David A Stenger; Marina Irvine; Donald Seto; Anjan Purkayastha; Nikki E Freed; Marylou G Gibson; Kevin Russell; David Metzgar
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

9.  Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery.

Authors:  Jason Seto; Michael P Walsh; Padmanabhan Mahadevan; Qiwei Zhang; Donald Seto
Journal:  Viruses       Date:  2010-01-06       Impact factor: 5.818

10.  The revolution in viral genomics as exemplified by the bioinformatic analysis of human adenoviruses.

Authors:  Sarah Torres; James Chodosh; Donald Seto; Morris S Jones
Journal:  Viruses       Date:  2010-06-28       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.